GB9005529D0 - Heterocyclic oligopeptides endowed with antitumor activity - Google Patents
Heterocyclic oligopeptides endowed with antitumor activityInfo
- Publication number
- GB9005529D0 GB9005529D0 GB909005529A GB9005529A GB9005529D0 GB 9005529 D0 GB9005529 D0 GB 9005529D0 GB 909005529 A GB909005529 A GB 909005529A GB 9005529 A GB9005529 A GB 9005529A GB 9005529 D0 GB9005529 D0 GB 9005529D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- oligopeptides
- endowed
- heterocyclic
- antitumor activity
- antitumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Indole Compounds (AREA)
- Quinoline Compounds (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9005529A GB2241950B (en) | 1990-03-12 | 1990-03-12 | Heterocyclic oligopeptides endowed with antitumor activity |
DE4106860A DE4106860A1 (en) | 1990-03-12 | 1991-03-04 | HETEROCYCLIC OLIGOPEPTIDES EQUIPPED WITH ANTITUM UMORACTIVITY |
ITMI910572A IT1250411B (en) | 1990-03-12 | 1991-03-05 | HETEROCYCLIC OLIGOPEPTIDES EQUIPPED WITH ANTI-TUMOR ACTIVITY |
JP3067875A JPH05148227A (en) | 1990-03-12 | 1991-03-07 | Heterocyclic oligopeptide having antitumor activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9005529A GB2241950B (en) | 1990-03-12 | 1990-03-12 | Heterocyclic oligopeptides endowed with antitumor activity |
Publications (3)
Publication Number | Publication Date |
---|---|
GB9005529D0 true GB9005529D0 (en) | 1990-05-09 |
GB2241950A GB2241950A (en) | 1991-09-18 |
GB2241950B GB2241950B (en) | 1993-05-12 |
Family
ID=10672473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9005529A Expired - Fee Related GB2241950B (en) | 1990-03-12 | 1990-03-12 | Heterocyclic oligopeptides endowed with antitumor activity |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPH05148227A (en) |
DE (1) | DE4106860A1 (en) |
GB (1) | GB2241950B (en) |
IT (1) | IT1250411B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004056768A2 (en) * | 2002-12-20 | 2004-07-08 | Bayer Healthcare Ag | Use of substituted 2,5-diamidoindoles for the treatment of urological diseases |
WO2016025692A1 (en) * | 2014-08-13 | 2016-02-18 | The Scripps Research Institute | Treatment of c9ftd/als by targeting rna expanded repeat sequences |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1521471A (en) * | 1974-06-05 | 1978-08-16 | Randall & Son Ltd J | Token-deposit locks |
-
1990
- 1990-03-12 GB GB9005529A patent/GB2241950B/en not_active Expired - Fee Related
-
1991
- 1991-03-04 DE DE4106860A patent/DE4106860A1/en not_active Withdrawn
- 1991-03-05 IT ITMI910572A patent/IT1250411B/en active IP Right Grant
- 1991-03-07 JP JP3067875A patent/JPH05148227A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
DE4106860A1 (en) | 1991-09-19 |
GB2241950A (en) | 1991-09-18 |
GB2241950B (en) | 1993-05-12 |
ITMI910572A0 (en) | 1991-03-05 |
ITMI910572A1 (en) | 1991-09-13 |
JPH05148227A (en) | 1993-06-15 |
IT1250411B (en) | 1995-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0470867A3 (en) | Electrochromic assembly | |
EP0468339A3 (en) | Alpha-keto-amide derivatives having protease inhibiting activity | |
GB2248809B (en) | Steering arrangement | |
EP0444520A3 (en) | Sensor arrangement | |
GB2231915B (en) | Hinge arrangement | |
GB2251227B (en) | Poultry-handling assembly | |
EP0446706A3 (en) | Peptides with tachykinin-agonistic or -antagonistic activity | |
GB9109030D0 (en) | Improved multi-keyring circuitry | |
ZA912572B (en) | Phosphonopeptides with collagenase inhibiting activity | |
GB2241950B (en) | Heterocyclic oligopeptides endowed with antitumor activity | |
GB9007976D0 (en) | Antenna arrangement | |
ZA911449B (en) | Aryl-propyl-amines endowed with antifungal activity | |
ZA912574B (en) | Phosphonopeptides with collagenase inhibiting activity | |
GB9022553D0 (en) | Speaker assembly | |
GB8914946D0 (en) | Heterocyclic oligopeptides endowed with antitumor activity | |
GB9024125D0 (en) | Antenna arrangement | |
EP0479122A3 (en) | Anti-glare arrangement | |
EP0464990A3 (en) | New restriction enzyme | |
GB2248013B (en) | Support arrangement and assembly | |
GB9011171D0 (en) | Assembling articles | |
GB9014748D0 (en) | Support arrangement | |
GB8828504D0 (en) | Hinge arrangement | |
EP0478962A3 (en) | Microwave-stripline assembly | |
GB9118742D0 (en) | Orientation enabling arrangement | |
GB2242923B (en) | Roller-shutter assembly |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19980312 |